ResMed Inc (RMD)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$227.39
Buy
$247.73
$-0.67 (-0.27%)
Prices updated at 04 Nov 2024, 12:44 EST
| Prices minimum 15 mins delay
Prices in USD
ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 56.67 |
2023 | 55.78 |
2022 | 56.57 |
2021 | 57.53 |
2020 | 58.09 |
2019 | 57.32 |
2018 | 57.04 |
2017 | 56.72 |
2016 | 58.00 |
2015 | 60.24 |
2014 | 63.65 |
Valuation data table
Year | Price / Sales |
---|---|
2024 | 7.48 |
2023 | 5.80 |
2022 | 8.45 |
2021 | 11.41 |
2020 | 10.24 |
2019 | 8.31 |
2018 | 6.82 |
2017 | 5.69 |
2016 | 4.64 |
2015 | 4.47 |
2014 | 5.10 |
Price/Forward earnings (YTD)
26.60
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | 14.99 |
2023 | 15.15 |
2022 | 15.87 |
2021 | 10.19 |
2020 | 14.30 |
2019 | 11.28 |
2018 | 9.66 |
2017 | 10.18 |
2016 | 12.96 |
2015 | 15.54 |
2014 | 15.10 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 1.41 |
2023 | 1.63 |
2022 | 1.52 |
2021 | 1.64 |
2020 | 1.84 |
2019 | 1.98 |
2018 | 1.49 |
2017 | 1.77 |
2016 | 1.92 |
2015 | 1.37 |
2014 | 1.34 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.